Eugenol in cloves: why it is the key chemical molecule

Eugenol is an aromatic molecule, meaning a plant-based substance that contributes to the scent of a food. It belongs to phenolic compounds (molecules with a specific chemical structure). This family helps to understand its role in cloves. The compound provides part of the spice's typical scent. Furthermore, it helps to interpret its phytochemical profile.

Its structure, however, does not by itself prove a clinical effect in humans. First, the role in the plant is studied, then the possible biological effects are evaluated. A World Health Organization guide on aromatic substances considers eugenol in its standards and safety guidelines [1]. A historical review (a review of studies) describes it as a phenolic compound widespread in essential oils. The same source also reports various already known uses [2]. These data explain why it is so widely studied, but they do not prove that it can cure diseases. Furthermore, the food matrix (the combination of parts of a food) can significantly change the results.

In cloves, eugenol is the main constituent of the volatile fraction. This is the part that produces the aroma and is released most easily. When analyzing the essential oil, eugenol therefore becomes the primary reference for the phytochemical profile. Its chemical weight helps explain the spice's distinct olfactory identity. For this reason, it is often used as a marker in product analyses.

A synthesis source reports that eugenol accounts for 70% to 90% of clove oil [3]. Another review confirms that it is the major volatile constituent of clove essential oil [4]. The data is solid, but requires caution. It primarily concerns a concentrated preparation, not the spice as a whole food. The result therefore clarifies the chemical weight of the various components. It does not, however, allow for direct conclusions about health to be drawn from composition data alone.

The amount of eugenol varies across different forms of cloves. The molecule is primarily found in the volatile fraction and in clove essential oil. The latter is a highly concentrated aromatic fraction. In the whole spice, other parts of the food reduce the weight of the individual compound. Therefore, a concentrated extract is not equivalent to the spice used in cooking. However, it may contain the same substance.

A small crossover study involved 10 healthy non-smoking men. In this type of study, each participant receives the different treatments. Researchers used 150 mg per day of the compound or a placebo for 7 days [5]. In research on human neutrophils and keratinocytes, the molecule was isolated from the spice [6]. Neutrophils and keratinocytes are cells of the immune system and the skin, respectively. The form used can therefore change what scientists observe. Pure doses and isolated cells aid research, but they do not replicate normal dietary use.

Eugenol contributes decisively to the warm, intense, and recognizable aroma of cloves. This aspect is not merely sensory: it helps explain why the molecule has also become a reference point in the scientific literature on the spice. In whole cloves, eugenol binds to other similar molecules. Together, they form the volatile component that the nose perceives first. This volatile component is the same one that scientists measure in laboratories. When a compound dominates the characteristic odor of a food, it becomes easier to link it to its chemical identity. It also becomes easier to use it as a key to interpret the phytochemical profile. For this reason, eugenol often appears in the composition tables of studies. Authors cite it first, precisely because of its aromatic and chemical weight.

The limitation remains fundamental: an intense aroma alone does not equate to a significant biological effect. Two spices can have a similar smell and very different chemistry. Eugenol guides the interpretation of the spice because it combines chemistry and perception into a single data point. The transition to biological activity, however, always requires context, dosage, and type of preparation. Without these elements, aroma alone is not enough to explain a real effect on the body.

In studies on cloves, eugenol does not always explain the observed effect on its own. Its strong presence suggests an important role in biological activity (effects on cells and tissues). However, the matrix, the type of product, and the study method also matter. The compound is therefore a good chemical marker, but it does not explain every result. It is necessary to distinguish the composition from hypotheses about mechanisms and actual effects in humans.

A review on the antioxidant and anti-inflammatory profile reports studies dedicated to these properties [7]. An ex vivo study (on isolated cells) shows antioxidant and anti-inflammatory effects. Researchers observed them in mononuclear cells from patients [8]. However, this is not a clinical study on nutrition. The experimental data therefore remains distant from daily use. This distance limits what we can conclude about the actual effects on people in everyday life. A correct interpretation acknowledges the possible role of eugenol without going beyond the available evidence.

The whole spice and the extract are not the same, even if they derive from the same plant. The former retains fiber and other substances dispersed throughout the plant tissue. The extract, on the other hand, collects a selected portion of phenolic compounds (plant substances with a specific chemical structure). Among these is eugenol. This difference changes the phytochemical profile and the significance of the collected data. A result obtained with a concentrate does not automatically apply to the spice used every day. Therefore, there is no form that is always "better." The chemical and dietary contexts change.

The review by Pramod, Kannissery; Ansari, Shahid H.; Ali, Javed indicates a precise fact. This molecule is the main constituent of clove oil, not of the spice in general [9]. This data explains why many studies use concentrated forms. However, these tests describe a denser and more selective product. They do not directly show what happens when the whole spice is part of a meal. The food matrix and the presence of fiber can modify the release of the molecule during digestion.

Clove essential oil is a fraction obtained primarily to collect volatile compounds—those that evaporate most easily and contribute strongly to the aroma. In this form, eugenol becomes much more prominent compared to the whole spice, as the most fragrant and analytically active component is enriched. For this reason, essential oil should not be understood simply as a “stronger” version of the spice: it is a concentrated extract with a different context of use and a different weight of individual constituents.

This data helps explain why the molecule appears so frequently in analyses of essential preparations. The limitation, however, is clear: a higher concentration does not by itself imply a proportional biological effect in the body, because dose, route of exposure, and the overall composition of the preparation also matter. The distillation process that produces the essential oil leaves behind sugars, minerals, and other non-volatile molecules present in the spice.

The volatile fraction is the part of the spice made up of compounds that transition most easily into the vapor phase and therefore significantly determine its scent. In cloves, this portion is central because it contains most of the aromatic molecule that characterizes the product's sensory and chemical profile. Speaking of the volatile fraction therefore means describing a precise segment of the plant material, not a generic synonym for potency. It is in this part that eugenol is easier to measure in concentrated preparations and more evident in laboratory analyses.

This helps explain why the volatile fraction is so relevant to the phenolic compound being studied. The interpretative limitation, however, remains the same: the chemical data describes the composition of the oil or extract, not the automatic biological response in humans. The volatile fraction is only one part of the phytocomplex, the set of all molecules present in the plant.

The biological significance of eugenol changes significantly depending on the form of intake. In culinary use of cloves, the molecule is delivered within a complex matrix and in smaller quantities; in a concentrated preparation, however, it is presented in a much denser form. For this reason, chemical data alone is not enough to describe the effect: the context of exposure also matters. A food and a concentrated extract may contain the same substance, but they do not automatically generate the same level of biological activity.

This is a useful result for understanding the molecule's behavior, but it is not a direct measure of the daily use of the spice. The main limitation is transferability: what happens with a standardized dose does not automatically overlap with a common meal or occasional aromatic use. Bioavailability, i.e., the amount actually absorbed by the body, can vary greatly between a capsule and cooked food.

Eugenol frequently appears in laboratory studies because it is an aromatic molecule that is easily isolated, making it suitable for observing cellular responses under controlled conditions. This makes it interesting for exploring bioactivity signals, especially when studying antioxidant or anti-inflammatory properties in simple models. The experimental advantage is clear: the compound lends itself well to repeatable tests with a known composition and measurable exposure. Precisely for this reason, however, laboratory results should be read as a first level of evidence, not as a clinical conclusion.

The limitation is fundamental: the observed activity depends on the cell type, dose, and experimental conditions, and therefore does not equate to a universal benefit in the human body.

Eugenol is being studied because, in various experimental models, it is associated with signals related to oxidative stress and inflammatory response. These are two key areas of research on phytochemicals, as they help us understand how a plant-derived molecule can interact with cellular function. The first area concerns the balance between oxidizing substances and cellular defenses. The second concerns the signals that activate or inhibit inflammation in tissues. The interest stems from the biological rationale, not from a promise of clinical effect: observing modulation in a laboratory does not mean demonstrating a benefit in humans. It is a first step, useful but not sufficient on its own.

Researchers use eugenol to map these interactions under controlled conditions. This approach allows for the isolation of cellular mechanisms without the variables of a whole organism. Individual reactions can thus be observed, step by step, with precision. The data is useful because it shows that biological activity depends on the experimental context, the concentration, and the cell type. Results therefore change depending on how the test is set up. For this reason, the topic of biological processes remains central, but it should be read as a map of hypotheses, not as proof of established efficacy.

Oxidative stress is one of the most frequent topics in eugenol literature because many phenolic phytocompounds are evaluated for their potential relationship with cellular defense systems. It involves a delicate balance between substances that damage cells and the mechanisms that protect them. In this context, the interest is mechanistic: researchers study whether and how the molecule influences the balance between reactive species and antioxidant mechanisms. Reactive species are unstable molecules that can damage cellular structures. The important point is not to immediately translate this observation into a therapeutic effect.

Tests measure the ability to neutralize free radicals in test tubes or cell cultures. These are simplified environments, far from the actual complexity of an organism. These experiments provide precise chemical data, but they do not reproduce the complexity of the human body. The molecule is therefore analyzed as a tool to understand bioactivity, not as direct proof of clinical benefit. A laboratory study on the relationship between chemical structure and biological activity describes the antioxidant action of eugenol as a chemically measured property, not as a clinical treatment [10].

The inflammatory response is also a recurring theme in studies on eugenol, as much research on phytocompounds seeks signs of modulation in cellular pathways involved in maintaining tissue homeostasis. This does not imply that the molecule acts in the same way in every context, nor that it produces a certain clinical outcome. However, the centrality of eugenol in cloves makes it a natural candidate for observing whether there are effects on inflammatory pathways in the laboratory. Preclinical models allow for the isolation of individual steps of the inflammatory cascade. Each step can be observed separately, without the interference typical of a whole organism.

This helps in formulating hypotheses about how the compound might act at the molecular level. The goal is to understand which signals are activated or blocked by the molecule. The picture should therefore be read as a biological hypothesis, not as confirmation of practical use. This type of data is valuable because it indicates that the inflammatory response can be modulated, but also that cellular tolerability matters as much as the desired effect. Indeed, an effect that is too pronounced could prove harmful rather than useful. For this very reason, the literature insists on comparing potential and limitations, rather than a simplified reading of anti-inflammatory effects.

One of the most common mistakes is to assume that results obtained in vitro—that is, in laboratory systems outside the body—or in animals are automatically transferable to humans. In the case of eugenol, this risk is particularly significant because the molecule is studied in highly controlled contexts, using doses and preparations that do not correspond to common dietary use. Laboratory data are useful for building hypotheses, not for drawing final conclusions. The concentrations used in the laboratory are often much higher than those achievable through diet.

Furthermore, absorption and metabolism in the body modify the molecule before it reaches the tissues. The body transforms the substances it consumes, and this often changes their actual effect. For this reason, the transition from cell to person always requires methodological caution. The model using rats made diabetic with STZ shows a metabolic rationale, but it remains an animal model, not proof of human use [11]. Animals, however useful, do not always replicate human physiology. In other words, the results help to understand the possible mechanism, but they are not enough to establish a reliable practical effect. It is precisely this distance between the laboratory and the organism that makes the topic so widely studied and, at the same time, so cautious to interpret.

Taken together, the available evidence describes eugenol as a well-characterized molecule, with consistent experimental interest regarding oxidation, inflammation, and essential oil composition. The strength of this framework lies in the convergence between regulatory sources, reviews, and laboratory studies, but the limitation remains the scarcity of direct human data. This means that the compound is scientifically relevant without yet being translatable into a solid practical conclusion for the general reader.

Systematic reviews confirm this gap between observed potential and missing clinical evidence. Studies on humans are needed to evaluate safety and efficacy under real-world conditions. These studies should clarify correct dosages, timing of action, and possible side effects. Only then will it be possible to understand if laboratory signals hold up in daily practice as well. For this reason, eugenol is currently studied as a concentrated extract of chemical and biological interest, but the correct interpretation remains cautious: great interest, promising data, and conclusions that are still partial.